Log in to save to my catalogue

Corifollitropin alfa for poor responders patients, a prospective randomized study

Corifollitropin alfa for poor responders patients, a prospective randomized study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9099868e3b4c4939a9351478872c2791

Corifollitropin alfa for poor responders patients, a prospective randomized study

About this item

Full title

Corifollitropin alfa for poor responders patients, a prospective randomized study

Publisher

England: BioMed Central Ltd

Journal title

Reproductive biology and endocrinology, 2020-07, Vol.18 (1), p.67-6, Article 67

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Poor ovarian response remains one of the biggest challenges for reproductive endocrinologists. The introduction of corifollitropin alpha (CFA) offered an alternative option to other gonadotropins for its longer half-life, its more rapid achievement of the threshold and higher FSH levels. We compared two different protocols with CFA, a long agonist...

Alternative Titles

Full title

Corifollitropin alfa for poor responders patients, a prospective randomized study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9099868e3b4c4939a9351478872c2791

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9099868e3b4c4939a9351478872c2791

Other Identifiers

ISSN

1477-7827

E-ISSN

1477-7827

DOI

10.1186/s12958-020-00628-6

How to access this item